Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of SAL-0951 for renal anemia in non-dialysis chronic kidney disease
ChiCTR2000040431Phase 3Not yet recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of enarodustat in anemia of chronic kidney disease (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Change in hemoglobin from baseline. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
enarodustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on ChiCTR2000040431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040431.